Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

TOBRAMYCIN AND DEXAMETHASONE

DEXAMETHASONE; TOBRAMYCIN

Standard Dose
0.1%;0.3%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TOBRAMYCIN AND DEXAMETHASONE is listed in Drugs@FDA under application 212991 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DEXAMETHASONE; TOBRAMYCIN Form and strength SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3% Sponsor AMNEAL Submission history Latest submission status date: 2021-07-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview TOBRAMYCIN AND DEXAMETHASONE is listed in Drugs@FDA under application 212991 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DEXAMETHASONE; TOBRAMYCIN Form and strength SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3% Sponsor AMNEAL Submission history Latest submission status date: 2021-07-15 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
TOBRAMYCIN AND DEXAMETHASONE (DEXAMETHASONE; TOBRAMYCIN) | Drug Monograph | MedicHelpline